Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Why Shares of Tesla Bobbed and Weaved Today: Is the Stock Back on Track?fool.com
Via The Motley Fool · April 2, 2025
Why Nike Stock Tumbled 20% in Marchfool.com
Via The Motley Fool · April 2, 2025
These S&P500 stocks are the most active in today's sessionchartmill.com
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · April 2, 2025
The Liberation Day Is Here – What To Expect From Gold & Coppercontent/com
Silver is up more than gold – outperforming it on an immediate-term basis. At the same time, miners are down. This is a classic short-term sell signal.
Via Talk Markets · April 2, 2025
Macro Briefing - Wednesday, April 2talkmarkets.com
Nonresidential construction spending rises to record levels in February.
Via Talk Markets · April 2, 2025
How Do Investors Really Feel About PTC?benzinga.com
Via Benzinga · April 2, 2025
Trumps Puzzletalkmarkets.com
Given the importance of inflation and interest rates to the economy and the financial markets, it’s worth assessing his clues and formulating some answers about what Donald Trump may be up to.
Via Talk Markets · April 2, 2025
These stocks are the most active in today's sessionchartmill.com
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · April 2, 2025
Tesla's Deliveries Are Down Sharply. Is it Time to Worry?fool.com
Protests and boycotts have driven many EV buyers to look elsewhere. Has Tesla's growth story stalled?
Via The Motley Fool · April 2, 2025
The FTSE Finish Line - Wednesday, April 2talkmarkets.com
UK stocks fell on Wednesday as global markets braced for U.S. President Donald Trump's announcement of reciprocal tariffs.
Via Talk Markets · April 2, 2025
Tesla Deliveries Drop 13% In Q1 2025 As Market Share, Subsidies, And Production Declinetalkmarkets.com
Tesla’s market share in 15 European countries dropped to 9.3% from 17.9%.
Via Talk Markets · April 2, 2025
Looking Into Cleveland-Cliffs's Recent Short Interestbenzinga.com
Via Benzinga · April 2, 2025
Is Fortinet Gaining or Losing Market Support?benzinga.com
Via Benzinga · April 2, 2025
Is the Market Bullish or Bearish on Abercrombie & Fitch?benzinga.com
Via Benzinga · April 2, 2025
7 Congress Members Have Bought And Sold Tesla Stock Since 2024 Election: A Look At Republicans And Democrats Betting On EV Giantbenzinga.com
Tesla has been a popular stock to own in recent years. Members of Congress owning the stock could have potential conflicts of interest with CEO Elon Musk now involved in the White House.
Via Benzinga · April 2, 2025
Why Nvidia Stock Lost 13% in Marchfool.com
Via The Motley Fool · April 2, 2025
Nvidia Stock Is Down Nearly 20% YTD: What's Going On?benzinga.com
NVIDIA Corp (NASDAQ: NVDA) shares have fallen 19.6% year to date, pressured by ongoing concerns about AI spending, trade restrictions and broader market weakness. The stock, which was one of the best-performing names in 2024, has struggled in 2025 as investors reassess growth expectations and adjust to an increasingly uncertain economic environment.
Via Benzinga · April 2, 2025
S&P 500: Chart Analysistalkmarkets.com
This is being caused by weakness in the stock market, which is reflected in the MACD.
Via Talk Markets · April 2, 2025
Looking Into KULR Tech Gr's Recent Short Interestbenzinga.com
Via Benzinga · April 2, 2025
How Do Investors Really Feel About Mirion Technologies?benzinga.com
Via Benzinga · April 2, 2025
Is A $15K Monthly Income And An $86K Emergency Fund Enough To Have A Baby In New York? Suze Orman Weighs Inbenzinga.com
Via Benzinga · April 2, 2025
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patientsbenzinga.com
NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.
Via Benzinga · April 2, 2025
Sportradar's Bets Big On Sports Data, Analyst Says Company Has Favorable Setupbenzinga.com
JP Morgan raises Sportradar's price target to $27, boosting 2026 revenue and EBITDA forecasts, driven by live betting and data innovation.
Via Benzinga · April 2, 2025
'Someone Asked Why '$75K Is Seen As A Low Salary On Reddit.' The Responses Actually Make More Sense Than You'd Expectbenzinga.com
Via Benzinga · April 2, 2025
4 Stocks I Would Avoid in 2025fool.com
Via The Motley Fool · April 2, 2025